Not applicableStudy completedNCT01617317What this trial is testingH-IVIG Treatment for Severe H1N1 2009Who this might be right forNovel 2009 Influenza A (H1N1) Infection The University of Hong Kong 34
Testing effectiveness (Phase 2)Study completedNCT00992433What this trial is testingH1N1 Vaccine at Two Dose Levels in HIV Positive AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 192
Testing effectiveness (Phase 2)Study completedNCT00976469What this trial is testingA/H1N1 Immunogenicity and Safety in Infants, Children and AdolescentsWho this might be right forInfluenzaPandemic Influenza Alachua Government Services, Inc. 400
Not applicableStudy completedNCT01089400What this trial is testingImmuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar LavageWho this might be right forInfluenzaAcute Lung InjuryAcute Respiratory Distress Syndrome Institut National de la Santé Et de la Recherche Médicale, France 30
Not applicableStudy completedNCT01023711What this trial is testingImmunologic Response to Inactivated Vaccine for Novel H1N1 VirusWho this might be right forInfluenza University of Rochester 107
Post-approval studies (Phase 4)Study completedNCT01246999What this trial is testingEffect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in ChildrenWho this might be right forInfluenza University of Rochester 34
Not applicableStudy completedNCT01000571What this trial is testingImmunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young AdultsWho this might be right forH1N1 Pandemic Flu St. Jude Children's Research Hospital 104
Large-scale testing (Phase 3)Study completedNCT01031719What this trial is testingClinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid TumorsWho this might be right forH1N1 Influenza VirusInvasive Solid Tumors Chiltern Pesquisa Clinica Ltda 59
Not applicableStudy completedNCT01271842What this trial is testingLong-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU StudyWho this might be right forInfluenzaPneumonia, ViralPulmonary Fibrosis+2 more Institut National de la Santé Et de la Recherche Médicale, France 38
Post-approval studies (Phase 4)Study completedNCT01079273What this trial is testingClinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy SubjectsWho this might be right forInfluenza Opera CRO, a TIGERMED Group Company 7
Not applicableStudy completedNCT01046331What this trial is testingNovel Influenza A (H1N1) Surveillance RegistryWho this might be right forNovel Influenza AH1N1Influenza National Heart, Lung, and Blood Institute (NHLBI) 894
Not applicableUnknownNCT04499378What this trial is testingTomographic Findings in COVID-19 and Influenza H1N1Who this might be right forCovid19Influenza A H1N1Intubation Complication+2 more Universidad de Guanajuato 200
Not applicableUnknownNCT01096238What this trial is testingFollow-up of Immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers After 6 MonthsWho this might be right forInfluenza National Taiwan University Hospital 185
Not applicableStudy completedNCT01037855What this trial is testingObservational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit VaccineWho this might be right forNovel Influenza A (H1N1)A New Flu Virus of Swine Origin Novartis Vaccines 4,028
Large-scale testing (Phase 3)Study completedNCT01032395What this trial is testingImmunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes MellitusWho this might be right forH1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more Chiltern Pesquisa Clinica Ltda 342
Large-scale testing (Phase 3)Study completedNCT00971425What this trial is testingEvaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)Who this might be right forInfluenza GlaxoSmithKline 145
Large-scale testing (Phase 3)Study completedNCT00971100What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 752
Large-scale testing (Phase 3)Study completedNCT00992511What this trial is testingStudy to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing ProcessesWho this might be right forInfluenza GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT00973349What this trial is testingSafety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly AdultsWho this might be right forInfluenza Novartis 2,719
Testing effectiveness (Phase 2)Study completedNCT00943878What this trial is testingSanofi H1N1 + TIV - Adults and ElderlyWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 805